Sale!

SETX Gene Ataxia-Oculomotor Apraxia Type 2 Genetic Test

4,400 د.إ

-21%

The SETX Gene Ataxia-Oculomotor Apraxia Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SETX gene. These mutations are responsible for causing Ataxia-Oculomotor Apraxia Type 2 (AOA2), a rare genetic disorder characterized by progressive cerebellar ataxia and oculomotor apraxia. Symptoms of AOA2 often manifest in late childhood or adolescence, leading to coordination problems, difficulty with eye movements, and neuropathy.

The test is particularly valuable for individuals showing symptoms of AOA2 or those with a family history of the disorder, as it provides critical insights into the genetic underpinnings of their condition. By analyzing a sample of the patient’s DNA, the test can confirm the presence of SETX gene mutations, enabling accurate diagnosis and guiding treatment decisions.

At a cost of 4400 AED, the SETX Gene Ataxia-Oculomotor Apraxia Type 2 Genetic Test at DNA Labs UAE represents a significant investment in personal health and genetic understanding. It is an essential resource for patients and families seeking clarity on this rare condition, offering a pathway towards more personalized care and management strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SETX Gene Ataxia-oculomotor apraxia type 2 Genetic Test

Are you or a loved one experiencing progressive problems with movement, coordination, and balance? DNA Labs UAE offers the SETX Gene Ataxia-oculomotor apraxia type 2 Genetic Test to help diagnose and manage this rare genetic disorder.

Test Details

The SETX gene is associated with a rare genetic disorder called ataxia-oculomotor apraxia type 2 (AOA2). This condition affects the nervous system and is characterized by progressive problems with movement, coordination, and balance. Individuals with AOA2 may also have difficulty with eye movements and may experience cognitive impairment.

NGS genetic testing can be used to identify mutations in the SETX gene that are associated with AOA2. This type of testing uses next-generation sequencing technology to analyze a person’s DNA and identify specific genetic changes that may be causing their symptoms. If a person is found to have a mutation in the SETX gene, they may receive a diagnosis of AOA2.

This genetic test is recommended for individuals who have symptoms of AOA2 or who have a family history of the disorder. Testing may also be recommended for individuals who are carriers of the gene mutation and are planning to have children.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the SETX Gene Ataxia-oculomotor apraxia type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with SETX Gene Ataxia-oculomotor apraxia type 2.

This information will help the medical professionals better understand the patient’s condition and provide appropriate guidance and treatment.

Don’t wait any longer to get answers. Contact DNA Labs UAE today to schedule your SETX Gene Ataxia-oculomotor apraxia type 2 Genetic Test.

Test Name SETX Gene Ataxia-oculomotor apraxia type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SETX Gene Ataxia-oculomotor apraxia type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SETX Gene Ataxia-oculomotor apraxia type 2
Test Details

The SETX gene is associated with a rare genetic disorder called ataxia-oculomotor apraxia type 2 (AOA2). This condition affects the nervous system and is characterized by progressive problems with movement, coordination, and balance. Individuals with AOA2 may also have difficulty with eye movements and may experience cognitive impairment.

NGS genetic testing can be used to identify mutations in the SETX gene that are associated with AOA2. This type of testing uses next-generation sequencing technology to analyze a person’s DNA and identify specific genetic changes that may be causing their symptoms.

If a person is found to have a mutation in the SETX gene, they may receive a diagnosis of AOA2. This can help guide their medical management and treatment, as well as inform genetic counseling and family planning decisions.

It is important to note that genetic testing for AOA2 is typically only recommended for individuals who have symptoms of the condition or who have a family history of the disorder. Testing may also be recommended for individuals who are carriers of the gene mutation and are planning to have children.